Abstract:Objective To analyse the amplitude characteristics of the compound muscle action potentials (CMAP) in patients with amyotrophic lateral sclerosis (ALS), and explore the correlation between CMAP amplitude and muscle strength, disease duration and neurological functional score. Methods The 127 patients of EMG presenting generalized neurogenic amyotrophic lateral sclerosis during May 2001-Nov 2004 were collected. These patients were diagnosed as definite cases 43, assume cases 39, probable cases 13 and suspicious cases 32 according to El Escorial diagnosis criterion. Among them a total of 82 cases of definite and assume cases were enrolled for evaluation by the amyotrophic lateral sclerosis function rating scale and Appel's amyotrophic laterosclerosis scale. Then the association of compound muscle action potential (CMAP) with changes of muscls strength, disease duration and neurological functional score was comparatively analyzed. Results Decreasing of CMAP amplitude correlated strongly with weakening of muscle strength, the relation could be fitted by an exponential equation (r = 0.969, P = 0.001); CMAP amplitude declined sharply or slowly over time to the same patient, the slower decline in CMAP amplitude correlated with a longer disease duration. There was no significant difference of muscle action potential amplitude levels among the different patients (r =- 0.077, P = 0.502). There was significant positive correlation of decreasing CMAP amplitude level with neurological functional score (r = 0.412, P = 0.001) but significant negative correlation with Appel's scale (r = - 0.549, P = 0.001). There was no simple linear correlation of decreasing CMAP amplitude with motor nerver conduction velocity (CV) (r =- 0.087, P = 0.545). But it presented linear correlation between the square roots when converting the amplitude and conductive velocity to the percentage of the lower limit of their normal levels and calculated their square root (r = 0.382, P < 0.001). Conclusion The changes of CMAP amplitude is resulted in both primary and secondary pathological changes of ALS. The CAMP significantly decreases when the exacerbation of ALS symptoms; but at that time, the conductive veloeity of motor nerve still keeps normal as the myelin sheath remains intact. Thus the mechanism of muscle strength decreasing in ALS is mainly due to the injury of motor nerve neurons. In the following up of patients, the CMAP amplitude is gradually decline as the disease course prolong in the same patient, but time-amplitude parallel relation curve could not be established yet. It shows the relation between CMAP amplitude change and disease course is rather complicate. The significant correlation of CMAP amplitude and the amyotrophic lateral sclerosis function rating scale of ALS patients or Apple's scale demonstrates that the slower of early decreasing amplitude, the milder the patient's condition.

The correlation of disease progression rate and repetitive nerve stimulation in patients with amyotrophic lateral sclerosis

Protein degradation and amino acid metabolism in autolyzing rabbit myocardium.

Repetitive Nerve Stimulation in Amyotrophic Lateral Sclerosis Patients

O-MN003. Decremental response to repetitive nerve stimulation occurs in early stage of amyotrophic lateral sclerosis

Quantitative evaluation of factors influencing the 3 Hz repetitive nerve stimulation test in patients with amyotrophic lateral sclerosis

Study on variation trend of repetitive nerve stimulation waveform in amyotrophic lateral sclerosis

Repetitive nerve stimulation as a diagnostic aid for distinguishing cervical spondylotic amyotrophy from amyotrophic lateral sclerosis

Median Nerve-Neurophysiological Index Correlates With the Survival of Patients With Amyotrophic Lateral Sclerosis

Quantitative evaluation of amyotrophic lateral sclerosis with differential law of nerve conduction velocity

Stratifying Disease Stages with Different Progression Rates Determined by Electrophysiological Tests in Patients with Amyotrophic Lateral Sclerosis.

Early Axonal Dysfunction of the Peripheral Nervous System Influences Disease Progression of ALS: Evidence From Clinical Neuroelectrophysiology

Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model

[Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis].

Selective and Inverse U-Shaped Curve Alteration of the Retinal Nerve in Amyotrophic Lateral Sclerosis: A Potential Mirror of the Disease

Early Axonal Dysfunction of the Peripheral Nervous System Influences Disease Progression of ALS: Evidences From Clinical Neuroelectrophysiology

Ultra-early amplitude decrement after repetitive nerve stimulation supports early neuromuscular junction injury in amyotrophic lateral sclerosis: a prospective cross-sectional study

ANALYSIS OF SURVIVAL TIME AND FUNCTIONAL PROGRESSION IN PATIENTS WITH AMYOTROPHIC LATERAL SCLEROSIS: A LONGITUDINAL STUDY

The correlation between clinical manifestations and features of compound muscle action potentials in patients with amyotrophic lateral sclerosis

Brain neurovascular coupling in amyotrophic lateral sclerosis: Correlations with disease progression and cognitive impairment

An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United States, and Europe

Denervation findings on EMG in amyotrophic lateral sclerosis and correlation with prognostic milestones: Data from a retrospective study